Finisa Rosenzweig

Obesity Medicine in Chicago, Illinois

Practice Details

Address
1300 W Belmont Ave Ste 400E
Chicago, IL 60657
Geocoded location: 41.9399, -87.6615
Taxonomy
Obesity Medicine (Preventive Medicine)
Credential
M.D.
NPPES Enumeration
Listed with NPPES since 2008
Sole Proprietor
Yes
Provider Gender (NPPES)
Female
NPPES Record Updated
June 2026

About This Clinician

This clinician is enumerated under Obesity Medicine, a Preventive Medicine subspecialty focused specifically on the medical management of obesity — including behavioral counseling, nutrition, and pharmacotherapy such as GLP-1 receptor agonists. Obesity-medicine specialists in Chicago are among the practices most likely to actively manage GLP-1 prescribing, though this registry entry does not confirm current prescribing practices.

Locally, this is 1 of 5 Obesity Medicine (Preventive Medicine) practices in Chicago carrying this exact taxonomy in our directory.

What to expect at an Obesity Medicine visit

A first visit at an obesity-medicine practice generally centers on a medical work-up rather than a quick prescription. In broad terms, patients often encounter:

  • A weight and health history, BMI/body-composition review, and discussion of prior weight-loss attempts.
  • A conversation about treatment options — lifestyle changes, and where appropriate anti-obesity medications such as GLP-1 receptor agonists (semaglutide, tirzepatide).
  • Baseline labs (e.g. A1c, metabolic panel, lipids) to screen for diabetes and metabolic conditions before starting medication.
  • A cost and coverage discussion, since many commercial plans limit obesity-only GLP-1 coverage and may require prior authorization.

This is general guidance for obesity medicine practices, not a description of Finisa Rosenzweig's specific protocol, services, or pricing. Confirm what a visit involves directly with the practice — 773-969-5752.

GLP-1 access in Chicago, Illinois

Adult obesity rate
32.4%
#26 of 50 states (CDC BRFSS)
Avg. compounded semaglutide
$209/mo
Typical Illinois telehealth cash price
Medicaid GLP-1 coverage
Diabetes + obesity (with prior auth)
Illinois Medicaid, obesity indication

About 32.4% of Illinois adults have obesity (BMI 30+), ranking the state #26 of 50 (CDC BRFSS). Our directory currently lists 314 GLP-1-relevant clinics in Chicago. If a cash-pay route makes more sense, compounded semaglutide through Illinois telehealth averages about $209/mo — well below brand-name Wegovy or Zepbound.

Explore more Illinois options on the best Illinois GLP-1 providers page, browse every Chicago listing in the Chicago clinic directory, or read the Illinois Medicaid GLP-1 coverage & prior-authorization guide.

Related Practices in Chicago

Other Chicago listings in the same directory tier:

Telehealth Alternative

Prefer not to visit in person? Licensed GLP-1 telehealth providers ship compounded semaglutide or tirzepatide directly to Illinois addresses, often faster and at lower cash cost than an in-person visit and brand-name prescription. Featured Illinois telehealth partners:

Featured Partners · Chicago

Featured GLP-1 providers serving Chicago

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more

  1. Top pick

    Compounded from

    $249.99/mo

    Save $1,099.01/mo vs Wegovy
    Get started →
  2. Compounded from

    $99/mo

    Save $1,250/mo vs Wegovy
    Get started →
  3. Compounded from

    $199/mo

    Save $1,150/mo vs Wegovy
    Get started →
  4. Compounded from

    $147/mo

    Save $1,202/mo vs Wegovy
    Get started →
  5. 8.2

    Compounded from

    $149/mo

    Save $937/mo vs Zepbound
    Get started →
  6. Compounded from

    $249/mo

    Save $1,100/mo vs Wegovy
    Get started →

See more Chicago options on the Chicago clinic directory, our Chicago GLP-1 telehealth page, or compare the best semaglutide providers nationwide.

Learn more about the medications most commonly prescribed by Chicago obesity-medicine and endocrinology practices: Semaglutide and Tirzepatide.

Frequently Asked Questions

The CMS National Provider registry lists Finisa Rosenzweig's specialty taxonomy but not the specific medications it prescribes or its current service menu. Finisa Rosenzweig is listed under Obesity Medicine, a field where GLP-1 medications such as semaglutide (Wegovy, Ozempic) or tirzepatide (Zepbound, Mounjaro) are commonly prescribed — but whether this practice currently offers them isn't recorded in the registry. Call the practice at 773-969-5752 to confirm before booking.
According to its CMS National Provider registry (NPPES) record, Finisa Rosenzweig's primary specialty on file is Obesity Medicine.
Finisa Rosenzweig is located at 1300 W Belmont Ave Ste 400E, Chicago, IL 60657. The phone number listed in the registry is 773-969-5752. Its full record is public in the CMS National Provider registry under NPI 1174781413.
New-patient status isn't recorded in the CMS National Provider registry, so we can't confirm whether Finisa Rosenzweig is currently accepting new patients. Call the practice at 773-969-5752 to confirm availability, cash-pay pricing, and whether the services you need are offered — this listing reflects the NPPES taxonomy on file and is not an endorsement.